Search Results - Hamano, Airi

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness

    What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness by Sekiguchi, Naohiro, Hamano, Airi, Kitagawa, Tomoko, Ito, Kenichi, Hirano, Kazuhiko, Yamada, Kazuaki

    Published in Blood research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent

    Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agen... by Sekiguchi, Naohiro, Hamano, Airi, Kitagawa, Tomoko, Kurihara, Yuya, Ito, Kenichi, Kurimoto, Miwa, Watanabe, Kozo, Hirano, Kazuhiko, Noto, Satoshi, Yamada, Kazuaki, Takezako, Naoki

    Published in Blood research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

    Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Thera... by Takezako, Naoki, Kaneko, Naoya, Hamano, Airi, Ito, Kenichi, Sekiguchi, Naohiro, Noto, Satoshi, Teshima, Takanori

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

    Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma by Suzuki, Kenshi, Abe, Yu, Miyazaki, Kanji, Sekine, Rieko, Tsukada, Nobuhiro, Hattori, Yutaka, Hamano, Airi, Shingaki, Sumito

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: